News and Updates

Details about the TrialNet study, including why Hydroxychloroquine, and the status of subject participation.

ViaCyte, a regenerative medicine company long-supported by Breakthrough T1D, today announced $27 million in financing to continue the development of beta cell therapies for diabetes. This funding ensures that Viacyte’s innovative approaches to replacing the insulin-producing beta cells in people with type 1 diabetes (T1D) will keep progressing. “Beta cell therapies are a key component […]

Virtual Visits Can Transform Care and Improve Outcomes for People with T1D

The American Diabetes Association’s (ADA) 80th Scientific Sessions is almost here! From June 12-16, scientists and healthcare professionals will gather, virtually, at one of the largest conferences of diabetes researchers in the world. Breakthrough T1D-funded researchers will also be there virtually to hear first-hand and present new study results that will improve outcomes for people […]

During a recent Breakthrough T1D Facebook Live event, a panel of leaders discussed Medtronic’s efforts to support the T1D community during the pandemic.

Mark Poznansky, M.D., Ph.D., wants the seemingly impossible—a person with type 1 diabetes (T1D) has a procedure where beta cells are placed in their body, the doctor stitches it up and the person has functioning insulin-producing beta cells, for life. Of course, we’re not there yet, but, with Dr. Poznansky—and many, many other researchers—Breakthrough T1D […]

How to access the latest diabetes management tools through the Department of Veterans Affairs with Armed For Diabetes .

In this time of great uncertainty, there is some exciting news out of Europe. Innodia, a partnership between public and private entities working together to fund research aimed at biomarker discovery and the prevention of type 1 diabetes (T1D), received an additional €12 million in funding from the European Commission, Breakthrough T1D and the Helmsley […]

Credit: Diabetes Care In December 2017, the type 1 diabetes (T1D) community got a jolt, when a publication, testing the insulin concentrations in 18 vials, said that “none of the vials met the minimum labeled concentration standard.” In other words, insulin was not at the recommended dose; in fact, the percentage of insulin was around […]

Wouldn’t it be nice if you could take a vaccine in infancy, and type 1 diabetes would not develop? Preclinical research suggests it might not be that far away.